Compare AMAR REMEDIES with BAJAJ CORP - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BAJAJ CONSUMER CARE - Comparison Results

BAJAJ CONSUMER CARE 
   Change

Bajaj Corp. Limited (BCL) is a leading producer of hair oils. It is part of the Shishir Bajaj Group of companies and subsidiary of Bajaj Consumer Care Limited (BCCL). The legacy of BCL began in 1953 when Bajaj Sevashram was established to market and ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BAJAJ CONSUMER CARE AMAR REMEDIES/
BAJAJ CONSUMER CARE
 
P/E (TTM) x -0.5 15.6 - View Chart
P/BV x 0.1 7.9 0.8% View Chart
Dividend Yield % 0.0 5.6 -  

Financials

 AMAR REMEDIES   BAJAJ CONSUMER CARE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BAJAJ CONSUMER CARE
Mar-19
AMAR REMEDIES/
BAJAJ CONSUMER CARE
5-Yr Chart
Click to enlarge
High Rs164510 32.2%   
Low Rs86308 27.9%   
Sales per share (Unadj.) Rs261.662.3 420.1%  
Earnings per share (Unadj.) Rs17.415.0 115.8%  
Cash flow per share (Unadj.) Rs22.315.5 143.7%  
Dividends per share (Unadj.) Rs014.00 0.0%  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs100.731.7 317.9%  
Shares outstanding (eoy) m26.16147.50 17.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.56.6 7.3%   
Avg P/E ratio x7.227.2 26.4%  
P/CF ratio (eoy) x5.626.4 21.3%  
Price / Book Value ratio x1.212.9 9.6%  
Dividend payout %093.2 0.0%   
Avg Mkt Cap Rs m3,27060,313 5.4%   
No. of employees `000NA1.3 0.0%   
Total wages/salary Rs m163972 16.8%   
Avg. sales/employee Rs ThNM7,289.5-  
Avg. wages/employee Rs ThNM771.2-  
Avg. net profit/employee Rs ThNM1,758.7-  
INCOME DATA
Net Sales Rs m6,8449,185 74.5%  
Other income Rs m21170 12.3%   
Total revenues Rs m6,8659,355 73.4%   
Gross profit Rs m1,1312,744 41.2%  
Depreciation Rs m12871 180.5%   
Interest Rs m39812 3,401.7%   
Profit before tax Rs m6262,832 22.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121616 19.7%   
Profit after tax Rs m4552,216 20.5%  
Gross profit margin %16.529.9 55.3%  
Effective tax rate %19.321.7 88.9%   
Net profit margin %6.624.1 27.6%  
BALANCE SHEET DATA
Current assets Rs m4,9044,250 115.4%   
Current liabilities Rs m3,5811,376 260.2%   
Net working cap to sales %19.331.3 61.8%  
Current ratio x1.43.1 44.3%  
Inventory Days Days12424 513.3%  
Debtors Days Days10015 674.2%  
Net fixed assets Rs m1,6891,769 95.5%   
Share capital Rs m262148 177.6%   
"Free" reserves Rs m2,3584,526 52.1%   
Net worth Rs m2,6354,674 56.4%   
Long term debt Rs m5070-   
Total assets Rs m6,8626,052 113.4%  
Interest coverage x2.6243.0 1.1%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.5 65.7%   
Return on assets %12.436.8 33.8%  
Return on equity %17.347.4 36.4%  
Return on capital %31.060.8 51.0%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273123 221.9%   
Fx outflow Rs m226 7.8%   
Net fx Rs m27197 278.7%   
CASH FLOW
From Operations Rs m-3131,764 -17.7%  
From Investments Rs m-489686 -71.3%  
From Financial Activity Rs m769-2,384 -32.2%  
Net Cashflow Rs m-3362 -52.5%  

Share Holding

Indian Promoters % 25.5 66.9 38.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 1.6 564.4%  
FIIs % 0.0 24.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 7.1 919.7%  
Shareholders   13,061 19,219 68.0%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   JYOTHY LABS  COLGATE  EMAMI LTD  K.S.OILS LTD  HUL  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Indian Indices Witness Selling, Key Q2FY20 Results, and Top Cues in Focus Today(Pre-Open)

India share markets ended their day deep in the red yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

BAJAJ CONSUMER CARE Announces Quarterly Results (2QFY20); Net Profit Up 10.9% (Quarterly Result Update)

Oct 14, 2019 | Updated on Oct 14, 2019

For the quarter ended September 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 573 m (up 10.9% YoY). Sales on the other hand came in at Rs 2 bn (up 2.1% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.

BAJAJ CONSUMER CARE Announces Quarterly Results (1QFY20); Net Profit Up 9.1% (Quarterly Result Update)

Jul 17, 2019 | Updated on Jul 17, 2019

For the quarter ended June 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 587 m (up 9.1% YoY). Sales on the other hand came in at Rs 2 bn (up 8.5% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.

BAJAJ CONSUMER CARE 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of BAJAJ CONSUMER CARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of BAJAJ CONSUMER CARE. Also includes updates on the valuation of BAJAJ CONSUMER CARE.

BAJAJ CONSUMER CARE Announces Quarterly Results (4QFY19); Net Profit Up 9.4% (Quarterly Result Update)

Apr 15, 2019 | Updated on Apr 15, 2019

For the quarter ended March 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 606 m (up 9.4% YoY). Sales on the other hand came in at Rs 2 bn (up 10.9% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.

BAJAJ CORP Announces Quarterly Results (3QFY19); Net Profit Up 8.9% (Quarterly Result Update)

Jan 11, 2019 | Updated on Jan 11, 2019

For the quarter ended December 2018, BAJAJ CORP has posted a net profit of Rs 601 m (up 8.9% YoY). Sales on the other hand came in at Rs 2 bn (up 10.3% YoY). Read on for a complete analysis of BAJAJ CORP's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS